REFERENCES
1. Russell S, Norvig P. Artificial intelligence: a modern approach. Third edition. Available from: https://people.engr.tamu.edu/guni/csce421/files/AI_Russell_Norvig.pdf. [Last accessed on 9 Oct 2023].
2. Bhinder B, Gilvary C, Madhukar NS, Elemento O. Artificial intelligence in cancer research and precision medicine. Cancer Discov 2021;11:900-15.
3. Moul JW, Snow PB, Fernandez EB, Maher PD, Sesterhenn IA. Neural network analysis of quantitative histological factors to predict pathological stage in clinical stage I nonseminomatous testicular cancer. J Urol 1995;153:1674-7.
4. Brodie A, Dai N, Teoh JY, Decaestecker K, Dasgupta P, Vasdev N. Artificial intelligence in urological oncology: an update and future applications. Urol Oncol 2021;39:379-99.
5. Checcucci E, Autorino R, Cacciamani GE, et al. Artificial intelligence and neural networks in urology: current clinical applications. Minerva Urol Nefrol 2020;72:49-57.
7. Laguna MP, Pizzocaro G, Klepp O, et al. EAU guidelines on testicular cancer. Eur Urol 2001;40:102-10.
8. Le Cornet C, Lortet-Tieulent J, Forman D, et al. Testicular cancer incidence to rise by 25% by 2025 in Europe? Model-based predictions in 40 countries using population-based registry data. Eur J Cancer 2014;50:831-9.
9. Isidori AM, Pozza C, Gianfrilli D, et al. Differential diagnosis of nonpalpable testicular lesions: qualitative and quantitative contrast-enhanced US of benign and malignant testicular tumors. Radiology 2014;273:606-18.
10. Pedersen MR, Sloth Osther PJ, Nissen HD, Vedsted P, Møller H, Rafaelsen SR. Elastography and diffusion-weighted MRI in patients with testicular microlithiasis, normal testicular tissue, and testicular cancer: an observational study. Acta Radiol 2019;60:535-41.
11. Rocher L, Criton A, Gennisson JL, et al. Characterization of testicular masses in adults: performance of combined quantitative shear wave elastography and conventional ultrasound. Ultrasound Med Biol 2019;45:720-31.
12. Pierre T, Selhane F, Zareski E, et al. The Role of CT in the staging and follow-up of testicular tumors: baseline, recurrence and pitfalls. Cancers 2022;14:3965.
13. Parenti GC, Feletti F, Carnevale A, Uccelli L, Giganti M. Imaging of the scrotum: beyond sonography. Insights Imaging 2018;9:137-48.
14. Tsili AC, Sofikitis N, Stiliara E, Argyropoulou MI. MRI of testicular malignancies. Abdom Radiol 2019;44:1070-82.
15. Zhang P, Feng Z, Cai W, et al. T2-weighted image-based radiomics signature for discriminating between seminomas and nonseminoma. Front Oncol 2019;9:1330.
16. Patrikidou A, Cazzaniga W, Berney D, et al. European association of urology guidelines on testicular cancer: 2023 update. Eur Urol 2023;84:289-301.
17. Lammers DT, Eckert CM, Ahmad MA, Bingham JR, Eckert MJ. A surgeon’s guide to machine learning. Ann Surg Open 2021;2:e091.
18. Albahra S, Gorbett T, Robertson S, et al. Artificial intelligence and machine learning overview in pathology & laboratory medicine: a general review of data preprocessing and basic supervised concepts. Semin Diagn Pathol 2023;40:71-87.
19. Morris MX, Rajesh A, Asaad M, Hassan A, Saadoun R, Butler CE. Deep learning applications in surgery: current uses and future directions. Am Surg 2023;89:36-42.
20. Feliciani G, Mellini L, Carnevale A, et al. The potential role of MR based radiomic biomarkers in the characterization of focal testicular lesions. Sci Rep 2021;11:3456.
21. Fan C, Sun K, Min X, et al. Discriminating malignant from benign testicular masses using machine-learning based radiomics signature of appearance diffusion coefficient maps: comparing with conventional mean and minimum ADC values. Eur J Radiol 2022;148:110158.
22. Society of Radiology (ESR). What the radiologist should know about artificial intelligence - an ESR white paper. Insights Imaging 2019;10:44.
23. Baessler B, Nestler T, Pinto Dos Santos D, et al. Radiomics allows for detection of benign and malignant histopathology in patients with metastatic testicular germ cell tumors prior to post-chemotherapy retroperitoneal lymph node dissection. Eur Radiol 2020;30:2334-45.
24. Lewin J, Dufort P, Halankar J, et al. Applying radiomics to predict pathology of postchemotherapy retroperitoneal nodal masses in germ cell tumors. JCO Clin Cancer Inform 2018;2:1-12.
25. Ghoshal B, Hikmet F, Pineau C, Tucker A, Lindskog C. DeepHistoClass: a novel strategy for confident classification of immunohistochemistry images using deep learning. Mol Cell Proteomics 2021;20:100140.
26. Serag A, Ion-Margineanu A, Qureshi H, et al. Translational AI and deep learning in diagnostic pathology. Front Med 2019;6:185.
27. Berney DM, Cree I, Rao V, et al. An introduction to the WHO 5th edition 2022 classification of testicular tumours. Histopathology 2022;81:459-66.
28. Wilkinson PM, Read G. International Germ Cell Consensus Classification: a prognostic factor-based staging system for metastatic germ cell cancers. International Germ Cell Cancer Collaborative Group. J Clin Oncol 1997;15:594-603.
29. Linder N, Taylor JC, Colling R, et al. Deep learning for detecting tumour-infiltrating lymphocytes in testicular germ cell tumours. J Clin Pathol 2019;72:157-64.
30. Ghosh A, Sirinukunwattana K, Khalid Alham N, et al. The potential of artificial intelligence to detect lymphovascular invasion in testicular cancer. Cancers 2021;13:1325.
31. Albers P, Siener R, Kliesch S, et al. Risk factors for relapse in clinical stage I nonseminomatous testicular germ cell tumors: results of the german testicular cancer study group trial. J Clin Oncol 2003;21:1505-12.
32. Katzman JL, Shaham U, Cloninger A, Bates J, Jiang T, Kluger Y. DeepSurv: personalized treatment recommender system using a Cox proportional hazards deep neural network. BMC Med Res Methodol 2018;18:24.
33. Lee C, Zame W, Yoon J, Van der Schaar M. DeepHit: a deep learning approach to survival analysis with competing risks. In: Proceedings of the AAAI Conference on Artificial Intelligence. 2018.
34. Nagpal C, Li X, Dubrawski A. Deep survival machines : fully parametric survival regression and representation learning for censored data with competing risks. IEEE J Biomed Health Inform 2021;25:3163-75.
35. Eminaga O, Shkolyar E, Breil B, et al. Artificial intelligence-based prognostic model for urologic cancers: a SEER-based study. Cancers 2022;14:3135.
36. Xu P, Wang J, Abudurexiti M, et al. Prognosis of patients with testicular carcinoma is dependent on metastatic site. Front Oncol 2019;9:1495.
37. Ding L, Wang K, Zhang C, et al. A machine learning algorithm for predicting the risk of developing to m1b stage of patients with germ cell testicular cancer. Front Public Health 2022;10:916513.
38. Tsili AC, Sofikitis N, Pappa O, Bougia CK, Argyropoulou MI. An overview of the role of multiparametric MRI in the investigation of testicular tumors. Cancers 2022;14:3912.
39. Tsili AC, Argyropoulou MI, Giannakis D, Tsampalas S, Sofikitis N, Tsampoulas K. Diffusion-weighted MR imaging of normal and abnormal scrotum: preliminary results. Asian J Androl 2012;14:649-54.
40. Wang W, Sun Z, Chen Y, et al. Testicular tumors: discriminative value of conventional MRI and diffusion weighted imaging. Medicine 2021;100:e27799.
41. Liu R, Li J, Jiang Y, et al. The utility of diffusion-weighted imaging and ADC values in the characterization of mumps orchitis and seminoma. Acta Radiol 2022;63:416-23.
42. Shen YT, Chen L, Yue WW, Xu HX. Artificial intelligence in ultrasound. Eur J Radiol 2021;139:109717.
43. Bini F, Pica A, Azzimonti L, et al. Artificial intelligence in thyroid field - a comprehensive review. Cancers 2021;13:4740.
44. Liu T, Guo Q, Lian C, et al. Automated detection and classification of thyroid nodules in ultrasound images using clinical-knowledge-guided convolutional neural networks. Med Image Anal 2019;58:101555.
45. Moldogazieva NT, Mokhosoev IM, Zavadskiy SP, Terentiev AA. Proteomic profiling and artificial intelligence for hepatocellular carcinoma translational medicine. Biomedicines 2021;9:159.
